Syndax Pharmaceuticals (Nasdaq: SNDX) granted inducement awards on May 1, 2026, to eight new employees to purchase up to 162,100 shares under its 2023 Inducement Plan. The stock options vest over four years: 25% at one year, then 1/48th monthly over the following 36 months, subject to continued service.
This announcement details routine inducement stock option grants for up to 162,100 shares to 8 new e...
Analysis
This announcement details routine inducement stock option grants for up to 162,100 shares to 8 new employees under Syndax’s 2023 Inducement Plan, vesting over four years with a one-year cliff and monthly vesting thereafter. It highlights continued use of equity compensation to attract and retain talent. In context of recent earnings showing strong revenue growth but ongoing losses, investors may monitor how cumulative equity awards evolve relative to hiring, expenses, and progress in late-stage programs.
Key Figures
Inducement option shares:162,100 sharesNew employees:8Vesting period:4 years+3 more
6 metrics
Inducement option shares162,100 sharesOptions to purchase common stock granted May 1, 2026
New employees8Recipients of inducement awards under 2023 Inducement Plan
Vesting period4 yearsTotal vesting duration for inducement stock options
Cliff vesting25%Portion vesting on one-year anniversary of vesting commencement
Monthly vesting fraction1/48thPortion vesting monthly after first year
Post-cliff vesting period36 monthsMonthly vesting duration following first-year cliff
Q4 and FY25 revenue growth from Revuforj and Niktimvo with narrowed losses.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Pattern Detected
Earnings and business updates have produced sizable moves, with one notable negative divergence on a strong Q1 2026 print, while routine items like inducement grants have seen modest to small reactions.
Recent Company History
Over the last several months, Syndax has transitioned firmly into a commercial-stage profile, with strong revenue growth from Revuforj and Niktimvo highlighted in Q4 2025 and Q1 2026 earnings on Feb 26, 2026 and Apr 30, 2026. Those reports showed rapid top-line expansion but ongoing net losses and high R&D plus SG&A. Alongside this, Syndax has repeatedly issued inducement equity grants under its 2023 Inducement Plan, like the March and April 2026 awards, indicating continued hiring and equity-based compensation practices consistent with today’s announcement.
"the Company granted inducement awards to purchase up to 162,100 shares"
Inducement awards are special bonuses given to new employees to encourage them to join a company, often in the form of stock or money. They matter because they can motivate talented people to choose one company over another and help align their success with the company's growth. Think of it like a signing bonus to seal the deal.
nasdaq listing rule 5635(c)(4)regulatory
"Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)"
NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.
stock optionsfinancial
"The stock options will vest over four years, with 25% of the underlying shares"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
vestingfinancial
"25% of the underlying shares vesting on the one-year anniversary"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on May 1, 2026, the Company granted inducement awards to purchase up to 162,100 shares of common stock to eight new employees under the Company's 2023 Inducement Plan. The stock options will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the vesting commencement date and 1/48th of the underlying shares vesting monthly thereafter over 36 months, subject to the employee's continued service relationship with Syndax through the applicable vesting dates.
About Syndax Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company's pipeline include Revuforj® (revumenib), an FDA-approved menin inhibitor, and Niktimvo™ (axatilimab-csfr), an FDA-approved monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment. For more information, please visit www.syndax.com or follow the Company on X and LinkedIn.
Syndax Contact
Sharon Klahre Syndax Pharmaceuticals, Inc. sklahre@syndax.com Tel 781.684.9827
FAQ
What inducement awards did Syndax (SNDX) grant on May 1, 2026?
The company granted inducement options to purchase up to 162,100 shares to eight new hires. According to the company, the awards were made under the 2023 Inducement Plan and are intended as new-hire equity compensation.
How do the SNDX inducement options vest and over what timeline?
Options vest over four years: 25% at one year, then 1/48th monthly over 36 months. According to the company, vesting is subject to each employee's continued service through the applicable vesting dates.
How many employees received inducement awards from Syndax (SNDX)?
Eight new employees received the inducement awards. According to the company, the grants were issued on May 1, 2026, under the company's 2023 Inducement Plan for new hires.
Will the SNDX inducement grants dilute existing shareholders?
The awards allow purchase of up to 162,100 shares, which could dilute existing holders if exercised. According to the company, actual dilution depends on future option exercises and outstanding shares at that time.
Where can investors find more details about Syndax (SNDX) inducement grants?
Investors can review company filings and investor materials for full terms and amounts. According to the company, the grants were made under the 2023 Inducement Plan and are described in its disclosures dated May 6, 2026.
